title: Influence of genotype and sex on the response of growing pigs to recombinant porcine somatotropin.
abstract: The dose-dependent effects of porcine somatotropin (pST) on growth performance and composition of carcass gain were investigated in 150 growing pigs. The experiment involved two genotypes (barrows from the Pig Improvement Company [PIC] and a University of Nebraska [NEB] gene pool line) and two sexes (PIC barrows and boars). At 30 kg, pigs were randomly assigned within each genotype and sex subclass to receive daily i.m. injections of 50, 100, 150, or 200 micrograms of pST/kg BW or an equivalent volume of an excipient. A diet (3.5 Mcal of DE/kg) supplemented with crystalline amino acids and containing 22.5% CP was available on an ad libitum basis until pigs were slaughtered at approximately 90 kg live weight. Excipient-treated PIC barrows exhibited faster and more efficient growth (P less than .001) and a higher capacity for carcass protein accretion (P less than .001) but similar rates of lipid deposition compared to excipient-treated NEB barrows. Within the PIC genotype, control boars grew at a rate similar to that of barrows, but they were more efficient (P less than .05) and deposited more carcass protein (P less than .05) and less lipid (P less than .001). Carcass protein accretion rate increased (P less than .001) up to approximately 150 micrograms of pST.kg BW-1.d-1, whereas lipid deposition decreased (P less than .001) with each incremental dose of pST. Although differences between PIC boars and barrows for all criteria were negated with increasing pST dose, they were maintained between the two genotypes. Polynomial regressions suggested that a slightly higher pST dose was required to optimize the feed:gain ratio compared with rate of gain and that the dose (micrograms per kilogram BW per day) was a function of the genotype and sex (feed:gain: 185, 170, and 155; rate of gain: 155, 155, and 125 for NEB barrows, PIC barrows, and PIC boars, respectively).
authors.affiliation: Department of Animal Science, Cornell University, Ithaca, NY 14853.
authors.forename: B J
authors.initials: BJ
authors.lastname: Krick
authors.forename: K R
authors.initials: KR
authors.lastname: Roneker
authors.forename: R D
authors.initials: RD
authors.lastname: Boyd
authors.forename: D H
authors.initials: DH
authors.lastname: Beermann
authors.forename: P J
authors.initials: PJ
authors.lastname: David
authors.forename: D J
authors.initials: DJ
authors.lastname: Meisinger
mesh_terms: D000273:Adipose Tissue / Q000254:growth & development; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001806:Blood Urea Nitrogen; D001823:Body Composition / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects; D005260:Female; D005838:Genotype; D013006:Growth Hormone / Q000494:pharmacology*; D008055:Lipids / Q000096:biosynthesis; D008297:Male; D008460:Meat / Q000592:standards; D024510:Muscle Development; D009124:Muscle Proteins / Q000096:biosynthesis; D011897:Random Allocation; D011994:Recombinant Proteins / Q000494:pharmacology; D012727:Sex Characteristics; D013552:Swine / Q000235:genetics / Q000254:growth & development*; D015430:Weight Gain / Q000187:drug effects* / Q000235:genetics
chemical_list: D001786:Blood Glucose; D008055:Lipids; D009124:Muscle Proteins; D011994:Recombinant Proteins; D013006:Growth Hormone